Peptides, Peptidomimetics and Small Molecule Inhibitors of the Epstein-Barr Virus Mediated Fusion and Entry Process
Disclosed are compositions and methods for modulating Epstein-Barr virus (EBV) infection in a patient. The compositions may include peptides or peptidomimetics that are related to gp42 and function to inhibit EBV-mediated membrane fusion.
KIRSCHNER AUSTIN N [US]; OMEROVIC JASMINA [BA]; LONGNECKER RICHARD [US]; JARDETZKY THEODORE S [US]
Type of Offer:
« More Biotech Patents